References
- Taglang G, Jackson DB. Use of “big data” in drug discovery and clinical trials. Gynecol Oncol. 2016;141:17–23.
- Lu P, Bevan DR, Leber A, et al. Computer-aided drug discovery. In: Bassaganya-Riera J, editor. Accelerated path to cures [Internet]. Cham: Springer International Publishing; 2018 [cited 2018 Dec 17]. p. 7–24. Available from: http://link.springer.com/10.1007/978-3-319-73238-1_2
- Ramsay RR, Popovic-Nikolic MR, Nikolic K, et al. A perspective on multi-target drug discovery and design for complex diseases. Clin Transl Med [Internet]. 2018 [cited 2018 Dec 17];7. Available from: https://clintransmed.springeropen.com/articles/10.1186/s40169-017-0181-2
- Katsila T, Spyroulias GA, Patrinos GP, et al. Computational approaches in target identification and drug discovery. Comput Struct Biotechnol J. 2016;14:177–184.
- Jing Y, Bian Y, Hu Z, et al. Deep learning for drug design: an artificial intelligence paradigm for drug discovery in the big data era. Aaps J [Internet]. 2018 [cited 2018 Dec 17];20. Available from: http://link.springer.com/10.1208/s12248-018-0210-0
- Brown N, Cambruzzi J, Cox PJ, et al. Chapter five - big data in drug discovery. In: Witty DR, Cox B, editors. Progress in Medicinal Chemistry [Internet]: Elsevier; 2018 [cited 2018 Nov 7]. p. 277–356. Available from: http://www.sciencedirect.com/science/article/pii/S0079646817300243
- Chen B, Butte A. Leveraging big data to transform target selection and drug discovery. Clin Pharmacol Ther. 2015;99:285–297.
- Constandt H. Disruptive change by linked data and semantic technologies in healthcare and life sciences. Drug Discovery World. 2013;14:72–76.
- Han Z-J, Xue -W-W, Tao L, et al. Identification of novel immune-relevant drug target genes for Alzheimer’s Disease by combining ontology inference with network analysis. CNS Neurosci Ther [Internet]. 2018 [cited 2018 Nov 7]. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/cns.13051.
- Tetko IV. Internet in drug design and discovery. Open Appl Inf J. 2008;2:18–21.
- Katsila T, Matsoukas M-T. How far have we come with contextual data integration in drug discovery? Expert Opin Drug Discov. 2018;13:791–794.
- Neumann EK, Miller E, Wilbanks J. What the semantic web could do for the life sciences. Drug Discovery Today: BIOSILICO. 2004;2:228–236.
- Frey JG. The value of the Semantic web in the laboratory. Drug Discov Today. 2009;14:552–561.
- Wild DJ, Ding Y, Sheth AP, et al. Systems chemical biology and the Semantic web: what they mean for the future of drug discovery research. Drug Discov Today. 2012;17:469–474.
- Chen H, Engkvist O, Wang Y, et al. The rise of deep learning in drug discovery. Drug Discov Today. 2018;23:1241–1250.
- Lavecchia A. Machine-learning approaches in drug discovery: methods and applications. Drug Discov Today. 2015;20:318–331.
- Zhang L, Tan J, Han D, et al. From machine learning to deep learning: progress in machine intelligence for rational drug discovery. Drug Discov Today. 2017;22:1680–1685.
- Machado CM, Rebholz-Schuhmann D, Freitas AT, et al. The semantic web in translational medicine: current applications and future directions. Brief Bioinform. 2015;16:89–103.
- Berners-Lee T, Hendler J, Lassila O. The Semantic web. Sci Am. 2001;284:34–43.
- Shadbolt N, Berners-Lee T, Hall W. The Semantic web revisited. IEEE Intell Syst. 2006;21:96–101.
- RDF - Semantic Web Standards [Internet]. [cited 2018 Nov 22]. Available from: https://www.w3.org/RDF/.
- R2RML: RDB to RDF Mapping Language [Internet]. [cited 2019 Feb 14]. Available from: https://www.w3.org/TR/r2rml/.
- Wilkinson MD, Dumontier M, Aalbersberg IJ, et al. The FAIR Guiding Principles for scientific data management and stewardship. Sci Data. 2016;3:160018.
- OWL - Semantic Web Standards [Internet]. [cited 2018 Nov 22]. Available from: https://www.w3.org/OWL/.
- RDFS - Semantic Web Standards [Internet]. [cited 2018 Nov 22]. Available from: https://www.w3.org/2001/sw/wiki/RDFS.
- OWL 2 Web Ontology Language Document Overview. 2nd ed [Internet]. [cited 2018 Nov 22. Available from. https://www.w3.org/TR/owl2-overview/
- SWRL: A Semantic Web Rule Language Combining OWL and RuleML [Internet]. [cited 2018 Dec 18]. Available from: https://www.w3.org/Submission/SWRL/.
- Chichester C, Digles D, Siebes R, et al. Drug discovery FAQs: workflows for answering multidomain drug discovery questions. Drug Discov Today. 2015;20:399–405.
- Li K, Rodosthenous RS, Kashanchi F, et al. Advances, challenges, and opportunities in extracellular RNA biology: insights from the NIH exRNA Strategic Workshop. JCI Insight [Internet]. [cited 2019 Feb 10];3. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928855/
- JSON-LD - JSON for Linking Data [Internet]. [cited 2018 Dec 7]. Available from: https://json-ld.org/.
- HTML Microdata [Internet]. [cited 2018 Dec 7]. Available from: https://www.w3.org/TR/microdata/.
- Djokic-Petrovic M, Cvjetkovic V, Yang J, et al. PIBAS FedSPARQL: a web-based platform for integration and exploration of bioinformatics datasets. J Biomed Semantics [Internet]. 2017 [cited 2019 Feb 15];8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607505/
- Horn Rules Semantics - W3C RIF-WG Wiki [Internet]. [cited 2019 Feb 14]. Available from: https://www.w3.org/2005/rules/wg/wiki/Horn_Rules_Semantics.html.
- SPIN - SPARQL Syntax [Internet]. [cited 2019 Feb 14]. Available from: https://www.w3.org/Submission/2011/SUBM-spin-sparql-20110222/.
- Shapes Constraint Language (SHACL) [Internet]. [cited 2019 Feb 14]. Available from: https://www.w3.org/TR/shacl/.
- RDF 1.1 Concepts and Abstract Syntax [Internet]. [cited 2018 Nov 22]. Available from: https://www.w3.org/TR/rdf11-concepts/.
- SPARQL 1.1 Overview [Internet]. [cited 2018 Nov 22]. Available from: https://www.w3.org/TR/2013/REC-sparql11-overview-20130321/.
- Semantic Web and Semantic Technology Trends in 2018 [Internet]. DATAVERSITY. 2017 [cited 2018 Nov 22]. Available from: http://www.dataversity.net/semantic-technology-semantic-web-trends-2018/.
- Introducing the Knowledge Graph: things, not strings [Internet]. Official google blog. [cited 2018 Nov 23]. Available from: https://googleblog.blogspot.com/2012/05/introducing-knowledge-graph-things-not.html.
- Borkum MI, Frey JG. Usage and applications of Semantic web techniques and technologies to support chemistry research. J Cheminform. 2014;6:18.
- SKOS Simple Knowledge Organization System Primer [Internet]. [cited 2018 Nov 22]. Available from: https://www.w3.org/TR/skos-primer/.
- Weibel S. The Dublin core: a simple content description model for electronic resources. Bull Am Soc Inf Sci Technol. 1997;24:9–11.
- Chen B, Dong X, Jiao D, et al. Chem2Bio2RDF: a semantic framework for linking and data mining chemogenomic and systems chemical biology data. BMC Bioinformatics. 2010;11:255.
- Chen H, Xie G. The use of web ontology languages and other semantic web tools in drug discovery. Expert Opin Drug Discov. 2010;5:413–423.
- Abeyruwan S, Vempati UD, Küçük-McGinty H, et al. Evolving bioassay ontology (BAO): modularization, integration and applications. J Biomed Semantics. 2014;5:S5.
- Lin Y, Mehta S, Küçük-McGinty H, et al. Drug target ontology to classify and integrate drug discovery data. J Biomed Semantics Internet. 2017;8:50. Available from: https://jbiomedsem.biomedcentral.com/articles/10.1186/s13326-017-0161-x.
- Sahoo SS, Valdez J, Kim M, et al. ProvCaRe: characterizing scientific reproducibility of biomedical research studies using semantic provenance metadata. Int J Med Inform [Internet]. 2018. [cited 2018 Nov 7]. Available from: http://www.sciencedirect.com/science/article/pii/S1386505618302697
- Ontotext’s Partnership with DrugBank to Open New Perspectives in Pharma Research [Internet]. Ontotext. [cited 2019 Feb 12]. Available from: https://www.ontotext.com/company/news/ontotexts-partnership-drugbank/.
- Gardner SP. Ontologies in drug discovery. Drug Discov Today. 2005;2:235–240.
- Vazquez-Naya J M, Martinez-Romero M, Porto-Pazos A B, et al. Ontologies of drug discovery and design for neurology, cardiology and oncology. Curr Pharm Des. 2010;16:2724–2736.
- Tao C, He Y, Arabandi SA. 2013 workshop: vaccine and drug ontology studies (VDOS 2013). J Biomed Semantics. 2014;5:16.
- Hanna J, Joseph E, Brochhausen M, et al. Building a drug ontology based on RxNorm and other sources. J Biomed Semantics. 2013;4:44.
- He Y, Cowell L, Diehl AD, et al. VO: vaccine Ontology. Nat Precedings [Internet]. 2009. [cited 2019 Feb 4]. Available from: http://precedings.nature.com/documents/3553/version/1
- Press TM. Building ontologies with basic formal ontology [Internet]. The MIT Press; [ cited 2019 Feb 4]. Available from: http://mitpress.mit.edu/books/building-ontologies-basic-formal-ontology
- Shen F, Lee Y. Knowledge discovery from biomedical ontologies in cross domains. PLOS ONE. 2016;11:e0160005.
- Gene Ontology: tool for the unification of biology. Nature Genetics [Internet]. [cited 2019 Feb 4]. Available from: https://www.nature.com/articles/ng0500_25.
- Foulger RE, Osumi-Sutherland D, McIntosh BK, et al. Representing virus-host interactions and other multi-organism processes in the Gene Ontology. BMC Microbiol [Internet]. 2015 [cited 2018 Nov 7];15. Available from: http://www.biomedcentral.com/1471-2180/15/146
- BioAssay Ontology; The BioAssay Ontology (BAO) describes chemical biology screening assays and their results including high-throughput screening (HTS) data for the purpose of categorizing assays and data analysis.BioAssay Ontology; The BioAssay Ontology (BAO) describes chemical biology screening assays and their results including high-throughput screening (HTS) data for the purpose of categorizing assays and data analysis [Internet]. [cited 2018 Nov 22]. Available from: http://bioassayontology.org/.
- Visser U, Abeyruwan S, Vempati U, et al. BioAssay Ontology (BAO): a semantic description of bioassays and high-throughput screening results. BMC Bioinformatics. 2011;12:257.
- Clark AM, Litterman NK, Kranz JE, et al. BioAssay templates for the semantic web. PeerJ Comput Sci. 2016;2:e61.
- Slenter DN, Kutmon M, Hanspers K, et al. WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research. Nucleic Acids Res. 2018;46:D661–D667.
- Vrandečić D, Krötzsch M. Wikidata: a free collaborative knowledgebase. Commun ACM. 2014;57:78–85.
- Guha RV, Brickley D, Macbeth S. Schema.org: evolution of structured data on the web. Commun ACM. 2016;59:44–51.
- Ekins S, Mietchen D, Coffee M, et al. Open drug discovery for the Zika virus. F1000Res [Internet]. 2016 [cited 2018 Dec 7];5. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841202/.
- Marshall LJ, Austin CP, Casey W, et al. Recommendations toward a human pathway-based approach to disease research. Drug Discov Today. 2018;23:1824–1832.
- Tang J, Tanoli Z-R, Ravikumar B, et al. Drug target commons: a community effort to build a consensus knowledge base for drug-target interactions. Cell Chem Biol. 2018;25:224–229.e2.
- Wild D Making semantics work in drug discovery [Internet]. [cited 2018 Dec 18]. Available from: http://scimaps.org/exhibit/images/130325/overview-semantics-wild.pdf.
- Semantic search (invited talk) - IEEE Conference Publication [Internet]. [cited 2018 Dec 12]. Available from: https://ieeexplore.ieee.org/abstract/document/8258348.
- Ekseth OK, Meyer JC, Hvasshovd SO A new database for drug discovery through application of data-integration and semantics. 2018 IEEE 12th International Conference on Semantic Computing (ICSC), Laguna Hills, CA; 2018. p. 403–410.
- Gray AJG, Groth P, Loizou A, et al. Applying linked data approaches to pharmacology: architectural decisions and implementation. Semant Web. 2014;5:101–113.
- Williams AJ, Harland L, Groth P, et al. Open PHACTS: semantic interoperability for drug discovery. Drug Discov Today. 2012;17:1188–1198.
- Dunlop I, Ramgolam R, Pettifer S, et al. Open PHACTS explorer bringing the web to the semantic web. 2013.
- Degtyarenko K, de Matos P, Ennis M, et al. ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 2008;36:D344–D350.
- Miller RA, Woollard P, Willighagen EL, et al. Explicit interaction information from WikiPathways in RDF facilitates drug discovery in the Open PHACTS Discovery Platform. F1000 Res. 2018;7:75.
- López-Massaguer O, Sanz F, Pastor M. An automated tool for obtaining QSAR-ready series of compounds using semantic web technologies. Bioinformatics. 2018;34:131–133.
- Data-driven drug development. Scientific computing world [Internet]. [cited 2019 Feb 12]. Available from: https://www.scientific-computing.com/lig2019/data-driven-drug-development.
- Chen L, Chu C, Lu J, et al. Gene ontology and KEGG pathway enrichment analysis of a drug target-based classification system. PLOS ONE. 2015;10:e0126492.
- Xu J, Hagler A. Chemoinformatics and drug discovery. Molecules. 2002;7:566–600.
- Ferrero E, Agarwal P. Connecting genetics and gene expression data for target prioritisation and drug repositioning. BioData Min. 2018;11:7.
- Andronis C, Sharma A, Virvilis V, et al. Literature mining, ontologies and information visualization for drug repurposing. Brief Bioinform. 2011;12:357–368.
- Chen B, Ding Y, Wild DJ. Assessing drug target association using semantic linked data. PLoS Comput Biol. 2012;8:e1002574.
- Ristoski P, Paulheim H. Semantic Web in data mining and knowledge discovery: A comprehensive survey. J Web Semant. 2016;36:1–22.
- Paulheim H, Ristoski P, Mitichkin E, et al. Data Mining with Background Knowledge from the Web:14.
- Malas TB, Kudrin R, Starikov S, et al. Semantic Knowledge Graph Network Features for Drug Repurposing. 2017.
- Sang S, Yang Z, Wang L, et al. SemaTyP: a knowledge graph based literature mining method for drug discovery. BMC Bioinformatics. 2018;19:193.
- Passi A, Rajput NK, Wild DJ, et al. RepTB: a gene ontology based drug repurposing approach for tuberculosis. J Cheminform. 2018;10:24.
- Cheng F, Liu C, Jiang J, et al. Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput Biol. 2012;8:e1002503.
- Fu G, Ding Y, Seal A, et al. Predicting drug target interactions using meta-path-based semantic network analysis. BMC Bioinformatics [Internet]. 2016 [cited 2018 Nov 7];17] Available from: http://bmcbioinformatics.biomedcentral.com/articles/10.1186/s12859-016-1005-x
- Olier I, Sadawi N, Bickerton GR, et al. Meta-QSAR: a large-scale application of meta-learning to drug design and discovery. Mach Learn. 2018;107:285–311.
- Herrero-Zazo M, Segura-Bedmar I, Hastings J, et al. DINTO: using OWL ontologies and SWRL rules to infer drug–drug interactions and their mechanisms. J Chem Inf Model. 2015;55:1698–1707.
- HiLIT | Lifesciences & Healthcare Platform | Vitrana [Internet]. [cited 2019 Feb 12]. Available from: http://www.vitrana.com/products/hilit/.
- Analytics C Clarivate analytics launches life science alliances program to accelerate innovation [Internet]. [cited 2019 Feb 12]. Available from: https://www.prnewswire.com/in/news-releases/clarivate-analytics-launches-life-science-alliances-program-to-accelerate-innovation-893047805.html.
- Zheng P, Zeng B, Liu M, et al. The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Sci Adv. 2019;5:eaau8317.
- Hu N Home [Internet]. NuMedii. [cited 2019 Feb 12]. Available from: http://numedii.com/.
- Dastgheib S, Webb C, Duan Q, et al. Accelerating Drug Discovery in Rare and Complex Diseases:2.
- Marcos E, Zhao B, He Y. The ontology of vaccine adverse events (OVAE) and its usage in representing and analyzing adverse events associated with US-licensed human vaccines. J Biomed Semantics. 2013;4:40.
- OAE: The Ontology of Adverse Events | Journal of Biomedical Semantics | Full Text [Internet]. [cited 2018 Dec 12]. Available from: https://jbiomedsem.biomedcentral.com/articles/10.1186/2041-1480-5-29.
- Semantic Web, and Other Technologies to Watch: January 2007 (1) [Internet]. [cited 2018 Dec 11]. Available from: https://www.w3.org/2007/Talks/0130-sb-W3CTechSemWeb/#(24).